chr3-186668924-G-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_000412.5(HRG):c.184-11G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0073 in 1,472,238 control chromosomes in the GnomAD database, including 53 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0051 ( 4 hom., cov: 32)
Exomes 𝑓: 0.0076 ( 49 hom. )
Consequence
HRG
NM_000412.5 intron
NM_000412.5 intron
Scores
2
Splicing: ADA: 0.0001642
2
Clinical Significance
Conservation
PhyloP100: -0.171
Genes affected
HRG (HGNC:5181): (histidine rich glycoprotein) This histidine-rich glycoprotein contains two cystatin-like domains and is located in plasma and platelets. The physiological function has not been determined but it is known that the protein binds heme, dyes and divalent metal ions. The encoded protein also has a peptide that displays antimicrobial activity against C. albicans, E. coli, S. aureus, P. aeruginosa, and E. faecalis. It can inhibit rosette formation and interacts with heparin, thrombospondin and plasminogen. Two of the protein's effects, the inhibition of fibrinolysis and the reduction of inhibition of coagulation, indicate a potential prothrombotic effect. Mutations in this gene lead to thrombophilia due to abnormal histidine-rich glycoprotein levels. [provided by RefSeq, Nov 2014]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant 3-186668924-G-T is Benign according to our data. Variant chr3-186668924-G-T is described in ClinVar as [Benign]. Clinvar id is 1234952.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 770 AD gene.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00507 AC: 770AN: 152002Hom.: 4 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
770
AN:
152002
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00511 AC: 1284AN: 251068 AF XY: 0.00494 show subpopulations
GnomAD2 exomes
AF:
AC:
1284
AN:
251068
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00756 AC: 9981AN: 1320122Hom.: 49 Cov.: 20 AF XY: 0.00722 AC XY: 4803AN XY: 664888 show subpopulations
GnomAD4 exome
AF:
AC:
9981
AN:
1320122
Hom.:
Cov.:
20
AF XY:
AC XY:
4803
AN XY:
664888
Gnomad4 AFR exome
AF:
AC:
27
AN:
30716
Gnomad4 AMR exome
AF:
AC:
204
AN:
44566
Gnomad4 ASJ exome
AF:
AC:
7
AN:
25242
Gnomad4 EAS exome
AF:
AC:
0
AN:
39036
Gnomad4 SAS exome
AF:
AC:
64
AN:
83424
Gnomad4 FIN exome
AF:
AC:
201
AN:
53190
Gnomad4 NFE exome
AF:
AC:
9124
AN:
982810
Gnomad4 Remaining exome
AF:
AC:
342
AN:
55636
Heterozygous variant carriers
0
463
925
1388
1850
2313
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
318
636
954
1272
1590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00506 AC: 770AN: 152116Hom.: 4 Cov.: 32 AF XY: 0.00452 AC XY: 336AN XY: 74364 show subpopulations
GnomAD4 genome
AF:
AC:
770
AN:
152116
Hom.:
Cov.:
32
AF XY:
AC XY:
336
AN XY:
74364
Gnomad4 AFR
AF:
AC:
0.00127674
AN:
0.00127674
Gnomad4 AMR
AF:
AC:
0.00405759
AN:
0.00405759
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0.00083091
AN:
0.00083091
Gnomad4 FIN
AF:
AC:
0.0037886
AN:
0.0037886
Gnomad4 NFE
AF:
AC:
0.00879645
AN:
0.00879645
Gnomad4 OTH
AF:
AC:
0.00569801
AN:
0.00569801
Heterozygous variant carriers
0
37
74
110
147
184
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at